|
|
12 Health Care Stocks Moving In Tuesday's Intraday Session
|
|
|
|
Protara Therapeutics shares are trading lower. The company announced updated interim results from its ongoing Phase 2 open-label ADVANCED-2 trial assessing intravesical TARA-002.
|
|
|
|
Ultra Clean Posts Downbeat Earnings, Joins Paymentus, Whirlpool And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
|
|
|
|
Protara's Experimental Bladder Cancer Drug Shows Encouraging Results
|
|
|
|
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
|
|
|
|
Why Keysight Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
|
|
|
|
Protara Therapeutics Announces Updated Interim Results From Ongoing Phase 2 Open-Label ADVANCED-2 Trial Assessing Intravesical TARA-002 In Patients With High-Risk NMIBC
|
|
|
|
HC Wainwright & Co. Reiterates Buy on Protara Therapeutics, Maintains $23 Price Target
|
|